Cellmid 2018 Annual Report 59
Business segment
Major customers
The Group has a number of customers to whom it provides both products and services. The Group supplies a single external
customer in the consumer health segment who accounts for 11.00% of external revenue (2017:19.78%). The next most
significant client accounts for 3.2% (2017: 3.4%) of external revenue.
Geographical segment
2018 2017 2018 2017 2018 2017
(Restated) (Restated)
$ $ $ $ $ $
Revenue
Sales to external customers 27,021 43,131 5,620,909 4,453,207 5,647,930 4,496,338
Total 27,021 43,131 5,620,909 4,453,207 5,647,930 4,496,338
Interest received 33,599 56,956 - - 33,599 56,956
Royalties and licences 64,252 147,520 - - 64,252 147,520
Other revenue - - 14,388 21,792 14,388 21,792
Total revenue 124,872 247,607 5,635,297 4,474,999 5,760,169 4,722,606
Other income
Government grant received 1,056,963 831,408 - - 1,056,963 831,408
Gain/Loss on disposal of assets - - - - - -
Other income 820 6,107 16,972 - 17,792 6,107
Expenses (2,333,165) (2,478,483) (7,459,642) (7,052,511) (9,792,807) (9,530,994)
Share-based compensation (111,490) (16,107) - - (111,490) (16,107)
Depreciation and amortisation (33,988) (24,943) (153,550) (143,580) (187,538) (168,523)
Finance costs (358,492) (240,468) (114,782) (50,705) (473,274) (291,173)
Profit / (Loss) before income tax (1,654,480) (1,674,879) (2,075,705) (2,771,797) (3,730,185) (4,446,676)
Income tax (expense) (2,430) (35,597)
Loss after income tax (3,732,615) (4,482,273)
Assets
Segment assets 2,501,037 4,565,019 4,247,540 3,583,372 6,748,577 8,148,391
Total assets 6,748,577 8,148,391
Liabilities
Segment liabilities (2,683,164) (2,576,342) (2,210,241) (1,501,023) (4,893,405) (4,077,365)
Total liabilities (4,893,405) (4,077,365)
Revenue Non-current assets Revenue Non-current assets
$ $ $ $
Australia and USA 1,533,647 712,369 1,715,909 739,373
Japan 4,226,522 1,877,125 3,006,697 1,846,716
Total 5,760,169 2,589,494 4,722,606 2,586,089
Midkine Consumer Health Total
2018 2017 (Restated)